Dixon Hubard Feinour & Brown’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $717K | Hold |
8,986
| – | – | 0.09% | 171 |
|
|
2022
Q1 | $945K | Sell |
8,986
-5,132
| -36% | -$540K | 0.09% | 167 |
|
|
2021
Q4 | $1.52M | Buy |
14,118
+313
| +2% | +$33.7K | 0.15% | 134 |
|
|
2021
Q3 | $1.51M | Hold |
13,805
| – | – | 0.32% | 64 |
|
|
2021
Q2 | $1.29M | Sell |
13,805
-22,220
| -62% | -$2.08M | 0.27% | 77 |
|
|
2021
Q1 | $2.99M | Buy |
36,025
+13,250
| +58% | +$1.1M | 0.37% | 64 |
|
|
2020
Q4 | $1.77M | Hold |
22,775
| – | – | 0.45% | 45 |
|
|
2020
Q3 | $1.77M | Hold |
22,775
| – | – | 0.45% | 45 |
|
|
2020
Q2 | $1.35M | Hold |
22,775
| – | – | 0.35% | 61 |
|
|
2020
Q1 | $675K | Hold |
22,775
| – | – | 0.23% | 77 |
|
|
2019
Q4 | $824K | Hold |
22,775
| – | – | 0.21% | 88 |
|
|
2019
Q3 | $620K | Buy |
22,775
+250
| +1% | +$6.81K | 0.17% | 100 |
|
|
2019
Q2 | $542K | Buy |
22,525
+5,925
| +36% | +$143K | 0.15% | 106 |
|
|
2019
Q1 | $439K | Buy |
+16,600
| New | +$439K | 0.13% | 111 |
|